[go: up one dir, main page]

BR9815470A - Composição e processo usando um eutÈmero - Google Patents

Composição e processo usando um eutÈmero

Info

Publication number
BR9815470A
BR9815470A BR9815470-2A BR9815470A BR9815470A BR 9815470 A BR9815470 A BR 9815470A BR 9815470 A BR9815470 A BR 9815470A BR 9815470 A BR9815470 A BR 9815470A
Authority
BR
Brazil
Prior art keywords
composition
eutomer
beta
improving
adrenergic
Prior art date
Application number
BR9815470-2A
Other languages
English (en)
Inventor
A K Gunnar Aberg
J Paul Fawcett
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of BR9815470A publication Critical patent/BR9815470A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"COMPOSIçãO E PROCESSO USANDO UM EUTÈMERO". Processo para aperfeiçoamento de saúde, sobrevivência e taxa de crescimento muscular de animais, enquanto reduzindo e aperfeiçoando a eficiência de alimentação por administração de um eutómero opticamente puro de um agonista beta-2 adrenérgico. A invenção também é direcionada a composições alimentícias compreendendo os agonistas de beta-2 adrenérgicos.
BR9815470-2A 1997-04-30 1998-04-29 Composição e processo usando um eutÈmero BR9815470A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4512097P 1997-04-30 1997-04-30
PCT/US1998/008611 WO1998048810A1 (en) 1997-04-30 1998-04-29 Composition and methods using an eutomer

Publications (1)

Publication Number Publication Date
BR9815470A true BR9815470A (pt) 2001-10-23

Family

ID=21936104

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815470-2A BR9815470A (pt) 1997-04-30 1998-04-29 Composição e processo usando um eutÈmero

Country Status (9)

Country Link
US (1) US6110974A (pt)
EP (1) EP0979081A4 (pt)
JP (1) JP2001527545A (pt)
AU (1) AU737608B2 (pt)
BR (1) BR9815470A (pt)
CA (1) CA2286913C (pt)
NO (1) NO995308L (pt)
NZ (1) NZ500250A (pt)
WO (1) WO1998048810A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254882B1 (en) * 1997-09-16 2001-07-03 Sepracor Inc. Methods and compositions for treating pulmonary disorders using optically pure (S)—salmeterol
US20050020692A1 (en) * 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
NZ547178A (en) * 2003-11-20 2008-06-30 Alteragon Pty Ltd Method of decreasing fat deposits and body weight in mammals and birdsusing the R-isomer of Salbutamol
DK1719507T3 (da) 2005-04-13 2010-11-01 Astion Dev As Beta-2 adrenoceptoragonister til behandling af bindevævsygdomme i huden
PL1921919T3 (pl) 2005-07-14 2012-09-28 Lithera Inc Ulepszona lipolityczna formulacja o podtrzymywanym uwalnianiu do traktowania lokalnej tkanki tłuszczowej
RU2431501C2 (ru) * 2005-07-14 2011-10-20 Липотера, Инк. Липолитические составы с пролонгированным высвобождением для локального лечения отложения жировых тканей
ES2398480T3 (es) * 2006-10-17 2013-03-19 Lithera, Inc. Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea
WO2009020620A1 (en) * 2007-08-06 2009-02-12 Bridge Pharma, Inc. Synergisms between repartitioning and immunomodulating compounds
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
MX2012008171A (es) * 2010-01-15 2012-12-17 Lithera Inc Formulaciones aglomeradas liofilizadas.
AU2011336869B2 (en) 2010-11-24 2016-09-15 Neothetics, Inc. Selective, lipophilic, and long-acting beta agonist monotherapeutic formulations and methods for the cosmetic treatment of adiposity and contour bulging

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8620951D0 (en) 1986-08-29 1986-10-08 Beecham Group Plc Compounds
US5530029A (en) * 1987-09-15 1996-06-25 The Rowett Research Institute Therapeutic applications of clenbuterol
US5541188A (en) * 1987-09-15 1996-07-30 The Rowett Research Institute Therapeutic applications of beta-adrenergic agonists
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
US4906645A (en) 1988-09-12 1990-03-06 Merck & Co., Inc. Pyridyl aminoethanol compounds with growth promotion and an increase in feed efficiency
AU7174191A (en) * 1990-01-05 1991-07-24 Sepracor, Inc. Optically pure r(-) albuterol for treating asthma
DE4014252A1 (de) 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
US5135954A (en) * 1991-05-24 1992-08-04 The Regents Of The University Of California Use of formoterol for treatment of tissue injury
SE9404080L (sv) * 1993-12-28 1995-06-29 Ciba Geigy Ag Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5708036A (en) * 1996-01-29 1998-01-13 Pesterfield, Jr.; E. Charles Method of treating premature uterine contractions using the optically active R(-)-isomer of albuterol
WO1997026871A1 (en) * 1996-01-29 1997-07-31 Savor, Evelyn Method of treating undesired uterine contractions using optically pure r- or rr-isomers of adrenergic beta-2 agonists

Also Published As

Publication number Publication date
EP0979081A4 (en) 2003-05-02
NO995308D0 (no) 1999-10-29
AU737608B2 (en) 2001-08-23
NO995308L (no) 1999-12-21
WO1998048810A1 (en) 1998-11-05
CA2286913A1 (en) 1998-11-05
AU7265098A (en) 1998-11-24
EP0979081A1 (en) 2000-02-16
US6110974A (en) 2000-08-29
NZ500250A (en) 2001-03-30
JP2001527545A (ja) 2001-12-25
CA2286913C (en) 2008-12-09

Similar Documents

Publication Publication Date Title
BR9815470A (pt) Composição e processo usando um eutÈmero
NO962665L (no) Forbindelser med veksthormonfrigjörende egenskaper
ZA983055B (en) Fungicidal trifluorophenyl-triazolopyrimidines.
NO955047D0 (no) Sekundære aminer som antidiabetiske og antifedme-midler
DK1235787T3 (da) Beta2-Adrenerge receptoragonister
TW200510277A (en) Crystalline form of β2-adrenergic receptor agonist
GB2333697A (en) Toothbrush
MY138220A (en) ARYL ANILINE ß2 ADRENERGIC RECEPTOR AGONISTS
MY121899A (en) In ovo vaccination against coccidiosis
YU70199A (sh) Primena stimulatora lučenja hormona rasta za izradu farmaceutskih preparata za lečenje otpornosti na insulin
BRPI0414634A (pt) agonistas de receptor b2, adrenérgico de etilamino amino-substituìdo
CA2373499A1 (en) Use of creatine as feed additive
PT81856B (pt) Processo para a preparacao de ingredientes activos a base de 3-(2,2-di-halogenovinil)2,2-dimetil-ciclopropano-carboxilatos de alfa-ciano-3-fenoxibenzilo e de composicoes insecticidas que os contem
PL352061A1 (en) Composition containing carvacrol and thymol for the use as a bacteriside
BG104916A (en) Calcilytic compounds
ATE423555T1 (de) Verwendung von beta-3-adrenergen-rezeptoren agonisten in der behandlung von dysurie
ES525915A0 (es) Un procedimiento para la preparacion de granulos de una composicion de pienso para animales.
CO5210926A1 (es) Mezclas fungicidas
RU97109038A (ru) Мясной корм для собак "чемпион+"
AU591730B2 (en) Use of phenethanol amines to improve fat content of sow's milk
DE69430259D1 (de) Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird
BR9809536A (pt) Mistura fungicida, processo para controlar fungos nocivos, uso dos compostos e, composição
EP1787529A3 (en) Composition and methods using an eutomer
BRPI9914996B1 (pt) composição de implante anabólico e processo para estimular a taxa aumentada de crescimento, maior quantidade de crescimento e maior eficiência de ração em um animal.
MX9705815A (es) AGONISTAS beta-ADRENERGICOS.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5O, 6O, 7O, 8O, E 9O ANUIDADES

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL: A61K 31/137, A61K 31/135, A61K 31/165, A61K 31/44, A61P 43/00, A23L 1/30

Ipc: A61K 31/137 (2008.04), A61K 31/135 (2008.04), A61K

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO ATENDE AO DISPOSTO NOS ARTIGOS 8O, 11, 13 E 25 DA LEI 9279/96 ( LPI )

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/167 (2006.01), A23K 20/111 (2016.0